Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Risk factors and prognosis in patients with suprachoroidal hemorrhage

Ozer Dursun, Omer Ozer, Mustafa Vatansever, Erdem Dinc.




Abstract

The aim of the present study is to evaluate the risk factors and prognosis after treatment in patients followed up for suprachoroidal hemorrhage (SCH). Six eyes of 6 patients who were followed up and treated for SCH between May 2016 and December 2021 were included in this study. All patients' risk factors, treatment, visual acuity and the anatomical result were evaluated separately. While 4 (66.7%) of the patients were male and 2 (33.3%) were female, the mean age of the patients was 72.5±12.5 years. There was a history of hypertension in 2 patients and a history of glaucoma in 3 patients. Surgery was performed under general anesthesia in 5 patients and under local anesthesia in 1 patient. While intraoperative SCH development was observed in four patients, SCH developed in 2 patients during the postoperative period. While hemorrhage drainage and pars plana vitrectomy were combined in one patient, 5 patients received only medical treatment. In the follow-up period, two patients had no perception of light, and one of these patients underwent evisceration. Perception of light was positive in one patient and anatomical integrity was preserved. The visual and anatomical results to be obtained from patients with SCH vary according to the severity of the situation, and very encouraging results cannot be obtained. The main strategy here is to prevent the development of SCH, and for this purpose, optimal precautions should be taken before, during and after surgery.

Key words: Prognosis, risk factors, suprachoroidal hemorrhage






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.